LifeLines

Interviews, insights, and innovation leading the way for life science.

Innovations

Ionis Achieves FDA Approval for DAWNZERA™, the First RNA-Targeted Preventive Therapy for Hereditary Angioedema (HAE)

August 22, 2025

Ionis Achieves FDA Approval for DAWNZERA™, the First RNA-Targeted Preventive Therapy for Hereditary Angioedema (HAE)

Insights

NCI SBIR Spotlights Pathways to $6.7M in Cancer Technology Funding

August 28, 2025

NCI SBIR Spotlights Pathways to $6.7M in Cancer Technology Funding

Interviews

Member Spotlight: Acurion

August 28, 2025

Member Spotlight: Acurion

Podcast

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

August 2, 2023

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

Your Story is Our Story

When it comes to CRISPR-based gene therapies, size isn’t just a detail—it’s a game-changer. Traditional gene editing relies on the Cas9 enzyme, a powerful tool but one with delivery and targeting challenges. Mammoth Biosciences is rewriting the rules with ultracompact Cas enzymes, enabling more precise in-vivo delivery, even in hard-to-reach tissues. Co-founded by CRISPR pioneer and Nobel laureate Jennifer Doudna, Ph.D., the company is moving beyond traditional gene splicing to develop more precise, controlled, and potentially safer therapies.

Join us for our video series, Your Story is Our Story, featuring groundbreaking achievements and exclusive behind-the-scenes looks at pioneering companies shaping the future of life science in California.

Learn More

Interviews

Member Spotlight

August 28, 2025

Member Spotlight: Acurion

Member Spotlight

April 30, 2025

Member Spotlight: Pivot Bio

Member Spotlight

March 6, 2025

Member Spotlight: ALX Oncology

Member Spotlight

November 7, 2024

Member Spotlight: Sapient Bioanalytics

Member Spotlight

October 10, 2024

Member Spotlight: MeCo Diagnostics

Insights

Event Recap

August 28, 2025

NCI SBIR Spotlights Pathways to $6.7M in Cancer Technology Funding

Insights

April 30, 2025

Progress Over Perfection: Highlights From Our 8th Annual Earth Day Sustainability Reception

Insights

March 5, 2025

Understanding the Impact of Critical Changes in Tariffs, Taxes and R&D Rules

Insights

January 23, 2025

Our Top Takeaways from JPM 2025: Resurgent Deals and Evolving Healthcare Policies

Members in Action

October 10, 2024

Guidelines for a Successful Laboratory Relocation: Why Timing, Planning and Communication Are Essential

Innovations

Members in the News

August 22, 2025

Ionis Achieves FDA Approval for DAWNZERA™, the First RNA-Targeted Preventive Therapy for Hereditary Angioedema (HAE)

Trending Topic

January 23, 2025

The Latest Advancements in Glaucoma Treatments and Ophthalmology

Members in Action

November 7, 2024

Veteran-Owned and Founded Biocom California Member Companies

Trending Topic

October 10, 2024

Biocom California Member Companies Advancing AI and Drug Discovery

Trending Topic

September 12, 2024

The Latest Happenings in Food and Ag Tech

Podcast

Season 1

August 2, 2023

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

Season 1

July 19, 2023

Episode 8: Building a Collaborative Incubator Community for Orange County Biotech Startups

Season 1

July 5, 2023

Episode 7: Mapping the Growth of the Bay Area’s Life Science Industry and Providing Startups with the Tools to Scale and Seed

Season 1

June 21, 2023

Episode 6: Landing Multi-Million Dollar Partnerships for Next-Gen Gene Therapies While Addressing Gender Parity in Life Science Leadership

Season 1

June 7, 2023

Episode 5: Creating a Bridge from Higher Education to Real-Life Science Application as a First-Ever Female Dean

Premium Members